283 related articles for article (PubMed ID: 28833834)
1. Estimates of effectiveness and reach for 'return on investment' modelling of smoking cessation interventions using data from England.
West R; Coyle K; Owen L; Coyle D; Pokhrel S;
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):19-31. PubMed ID: 28833834
[TBL] [Abstract][Full Text] [Related]
2. Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development.
West R; Raw M; McNeill A; Stead L; Aveyard P; Bitton J; Stapleton J; McRobbie H; Pokhrel S; Lester-George A; Borland R
Addiction; 2015 Sep; 110(9):1388-403. PubMed ID: 26031929
[TBL] [Abstract][Full Text] [Related]
3. Estimates of costs for modelling return on investment from smoking cessation interventions.
Trapero-Bertran M; Leidl R; Muñoz C; Kulchaitanaroaj P; Coyle K; Präger M; Józwiak-Hagymásy J; Cheung KL; Hiligsmann M; Pokhrel S;
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):32-41. PubMed ID: 29532538
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD.
Trapero-Bertran M; Muñoz C; Coyle K; Coyle D; Lester-George A; Leidl R; Németh B; Cheung KL; Pokhrel S; Lopez-Nicolás Á
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):65-75. PubMed ID: 29532966
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Cahill K; Stevens S; Perera R; Lancaster T
Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
[TBL] [Abstract][Full Text] [Related]
6. E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT.
Hajek P; Phillips-Waller A; Przulj D; Pesola F; Smith KM; Bisal N; Li J; Parrott S; Sasieni P; Dawkins L; Ross L; Goniewicz M; Wu Q; McRobbie HJ
Health Technol Assess; 2019 Aug; 23(43):1-82. PubMed ID: 31434605
[TBL] [Abstract][Full Text] [Related]
7. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
[TBL] [Abstract][Full Text] [Related]
8. Moderators of real-world effectiveness of smoking cessation aids: a population study.
Jackson SE; Kotz D; West R; Brown J
Addiction; 2019 Sep; 114(9):1627-1638. PubMed ID: 31117151
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cost-effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD.
Anraad C; Cheung KL; Hiligsmann M; Coyle K; Coyle D; Owen L; West R; de Vries H; Evers SM; Pokhrel S
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):96-105. PubMed ID: 29430762
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD.
Huber MB; Präger M; Coyle K; Coyle D; Lester-George A; Trapero-Bertran M; Nemeth B; Cheung KL; Stark R; Vogl M; Pokhrel S; Leidl R
Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):52-64. PubMed ID: 29243347
[TBL] [Abstract][Full Text] [Related]
11. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
[TBL] [Abstract][Full Text] [Related]
12. Interventions to reduce harm from continued tobacco use.
Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
[TBL] [Abstract][Full Text] [Related]
13. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
Coleman T; Agboola S; Leonardi-Bee J; Taylor M; McEwen A; McNeill A
Health Technol Assess; 2010 Oct; 14(49):1-152, iii-iv. PubMed ID: 21040645
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of use and real-world effectiveness of smoking cessation aids during the COVID-19 pandemic: a representative study of smokers in England.
Jackson SE; Cox S; Shahab L; Brown J
Addiction; 2022 Sep; 117(9):2504-2514. PubMed ID: 35491743
[TBL] [Abstract][Full Text] [Related]
15. Nicotine receptor partial agonists for smoking cessation.
Livingstone-Banks J; Fanshawe TR; Thomas KH; Theodoulou A; Hajizadeh A; Hartman L; Lindson N
Cochrane Database Syst Rev; 2023 May; 5(5):CD006103. PubMed ID: 37142273
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR
Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Tobacco Smoking: A Review.
Rigotti NA; Kruse GR; Livingstone-Banks J; Hartmann-Boyce J
JAMA; 2022 Feb; 327(6):566-577. PubMed ID: 35133411
[TBL] [Abstract][Full Text] [Related]
18. Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.
Getsios D; Marton JP; Revankar N; Ward AJ; Willke RJ; Rublee D; Ishak KJ; Xenakis JG
Pharmacoeconomics; 2013 Sep; 31(9):767-80. PubMed ID: 23821436
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants for smoking cessation.
Hajizadeh A; Howes S; Theodoulou A; Klemperer E; Hartmann-Boyce J; Livingstone-Banks J; Lindson N
Cochrane Database Syst Rev; 2023 May; 5(5):CD000031. PubMed ID: 37230961
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
